As of 2025-03-19, the EV/EBITDA ratio of Inari Medical Inc (NARI) is -138.50. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. NARI's latest enterprise value is 4,641.90 mil USD. NARI's TTM EBITDA according to its financial statements is -33.52 mil USD. Dividing these 2 quantities gives us the above NARI EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 9.0x - 12.2x | 9.6x |
| Forward P/E multiples | 11.6x - 18.0x | 13.2x |
| Fair Price | (5.93) - (6.27) | (5.81) |
| Upside | -107.4% - -107.8% | -107.3% |
| Date | EV/EBITDA |
| 2025-02-19 | -138.50 |
| 2025-02-18 | -138.50 |
| 2025-02-14 | -138.43 |
| 2025-02-13 | -138.43 |
| 2025-02-12 | -138.41 |
| 2025-02-11 | -138.34 |
| 2025-02-10 | -138.31 |
| 2025-02-07 | -138.13 |
| 2025-02-06 | -138.32 |
| 2025-02-05 | -138.36 |
| 2025-02-04 | -138.29 |
| 2025-02-03 | -137.89 |
| 2025-01-31 | -137.97 |
| 2025-01-30 | -138.01 |
| 2025-01-29 | -138.03 |
| 2025-01-28 | -137.85 |
| 2025-01-27 | -137.89 |
| 2025-01-24 | -138.10 |
| 2025-01-23 | -137.61 |
| 2025-01-22 | -137.54 |
| 2025-01-21 | -137.68 |
| 2025-01-17 | -137.76 |
| 2025-01-16 | -137.50 |
| 2025-01-15 | -137.50 |
| 2025-01-14 | -137.33 |
| 2025-01-13 | -137.40 |
| 2025-01-10 | -137.31 |
| 2025-01-08 | -137.33 |
| 2025-01-07 | -137.59 |
| 2025-01-06 | -112.34 |
| 2025-01-03 | -85.73 |
| 2025-01-02 | -89.28 |
| 2024-12-31 | -87.97 |
| 2024-12-30 | -89.51 |
| 2024-12-27 | -91.32 |
| 2024-12-26 | -93.18 |
| 2024-12-24 | -92.51 |
| 2024-12-23 | -91.79 |
| 2024-12-20 | -95.66 |